News
Google News: BASF-Aktie: Management zeigt sich unerwartet optimistisch
[AktienCheck] - Amsterdam (www.aktiencheck.de) - Fabian Smeets, Analyst der ING, stuft die Aktie von BASF (ISIN DE000BASF WKN BASF11) unverändert mit "hold" ein und bestätigt das 12-Monats-Kursziel von 52,00 EUR. Während der Umsatz des vierten Quartals 7% besser
AkzoNobel to shine on savings – Business Recorder
fp.brecorder.com
"It is time for the cost savings to reign," said Rabo Securities analyst Fabian Smeets. "Most other chemicals companies have already finished ...
Johnson & Johnson to buy Crucell
www.arkansasonline.com
Johnson & Johnson said it will buy the rest of vaccine maker Crucell NV it doesn’t already own for $2.3 billion, expanding in flu shots to bolster sales...
Johnson & Johnson gets a shot in the arm with Dutch deal | London...
www.standard.co.uk
But the likelihood of a bidding war is small," said Fabian Smeets, analyst at Rabo Securities. J&J has already finished due diligence on the deal ...
sortiert nach Relevanz / Datum